ArticleFrontiers in immunology2025

An explorable model of an adverse outcome pathway of cytokine release syndrome related to the administration of immunomodulatory biotherapeutics and cellular therapies.

Alexander Mazein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.